Carcinoma in Situ
📧 Sign up to get email alerts when something new happens for Carcinoma in Situ.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-24Clinical Trial Results: Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer [Phase 3]
Phase 3 trial evaluating a web-based physical activity intervention aimed at improving long-term health outcomes in pediatric cancer patient…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: E7 TCR T Cells for Human Papillomavirus-Associated Cancers [Phase 1, Phase 2]
Phase 1/2 trial of E7 TCR T cells for human papillomavirus–associated cancers has completed with results posted.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Project: Every Child for Younger Patients With Cancer
Clinical trial update from the Children's Oncology Group shows that the multi-indication pediatric trial 'Project: Every Child for Younger P…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer [Phase 3]
Phase 3 clinical trial update on a web-based physical activity intervention to improve long-term health in children and adolescents with can…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices [NA]
A completed clinical trial evaluating a virtual tobacco treatment for cancer patients in community oncology practices, with results posted o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-11-22Clinical Trial Update: A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. [Phase 4]
A Phase 4 trial evaluating reinduction with Nadofaragene firadenovec in bladder cancer patients with CIS ± high-grade Ta/T1 and no complete …
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer [Phase 2, Phase 3]
Phase 2/3 trial of recombinant adenovirus for non-muscle invasive bladder cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Localization of Nonpalpable Breast Lesions [NA]
The clinical trial 'Localization of Nonpalpable Breast Lesions' conducted by Rigshospitalet in Denmark has completed. The update covers cond…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus [Phase 1]
Phase 1 trial to determine the maximum safe range of light doses for photodynamic therapy using HPPH in Barrett's esophagus with high-grade …